Consensus ESG Ratings
Member Sign In
ESG News For Pharmaceutical Product Development, Inc. (PPD)
These sites contributed news to this page:
-
Thermo Fisher Scientific Releases 2023 Corporate Social Responsibility Report
Report highlights company’s commitments to all of its stakeholders and society -
Thermo Fisher Scientific and Project HOPE Partner to Advance Health Equity Among HIV Positive Youth in Sub-Saharan Africa
Collaboration designed to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria -
Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity
Thermo Fisher’s latest net-zero milestone to be achieved through 200-megawatt solar project -
Thermo Fisher Scientific and Society for Science Launch Junior Innovators Challenge to Inspire More Than 65,000 Future STEM Leaders Nationwide
Educators and school officials encouraged to drive student awareness of state and regional science fairs for a chance to enter nation’s premier middle school STEM competition -
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
The agreement will deliver renewable energy equal to half of the company’s U.S. electricity consumption -
Journal of Psychoactive Drugs Publishes Peer Reviewed Ketamine Research Foundation Study on the Duration of the Presence of Ketamine in Breast Milk
The research opens the door to ketamine-assisted psychotherapy (KAP) as a first-line antidepressant for women who are breastfeeding and suffering from postpartum depression (PPD).